quantit
method
measur
human
immunodefici
viru
type
integr
promis
import
tool
dissect
mechan
wherebi
latent
reservoir
proviru
establish
notabl
rest
cell
patient
receiv
antiretrovir
therapi
describ
fluorescencemonitor
nest
pcr
assay
abl
quantifi
rel
rare
integr
event
occur
within
cell
follow
dna
extract
nonkinet
preamplif
step
perform
primer
bind
genom
alu
element
gag
sequenc
condit
primer
deoxynucleosid
triphosph
enzym
limit
follow
kinet
pcr
quantit
long
termin
repeat
sequenc
tcellbas
integr
standard
reflect
random
integr
also
describ
assay
time
sensit
previous
report
quantit
alu
pcrbase
integr
assay
specif
integr
event
sinc
provirus
detect
cell
infect
either
presenc
integras
inhibitor
integrasedefici
viru
method
promis
provid
import
new
insight
process
underli
accumul
persist
latent
reservoir
may
eventu
use
clinic
monitor
erad
latent
viru
novel
therapi
integr
oblig
step
retroviru
replic
defin
coval
insert
viral
dna
host
cell
genom
human
immunodefici
viru
type
provirus
appear
contribut
viral
persist
evid
treat
patient
provir
load
seem
unaffect
combin
antiretrovir
therapi
clear
viremia
date
provir
dna
proven
imposs
erad
without
death
transduc
host
cell
result
suggest
proviru
may
serv
treatmentresist
reservoir
quantit
studi
reservoir
challeng
rel
rariti
integr
event
quiescent
leukocyt
assay
integr
implement
use
three
main
strategi
name
invers
pcr
linkerprim
pcr
alu
pcr
focu
refin
latter
method
alu
element
numer
repetit
element
primat
genom
dna
compris
million
copi
per
diploid
cell
mass
human
genom
continu
accumul
rate
insert
everi
live
birth
via
rna
polymeras
iiidepend
process
call
retroposit
alu
element
randomli
distribut
roughli
bp
apart
randomli
orient
earli
integr
assay
util
alu
repeat
element
anchor
within
genom
dna
sensit
strictli
quantit
sinc
lack
realtim
reaction
monitor
polyclon
standard
particular
studi
use
genom
dna
prepar
grade
dose
persist
infect
cell
line
mixtur
line
standard
problem
cell
line
clonal
contain
one
two
two
nonrandom
integr
site
respect
standard
prepar
line
like
underor
overestim
number
integr
event
nearli
type
unknown
sinc
provirus
cell
line
harbor
integr
specif
nonvari
distanc
alu
repeat
within
genom
singl
integr
event
detect
clonal
dna
standard
presum
aris
integr
site
rel
close
nearest
alu
element
howev
assign
number
signal
implicit
assumpt
must
made
integr
event
unknown
must
also
detect
pcr
due
random
natur
integr
alu
retroposit
alugag
integr
site
nonclon
collect
infect
cell
amplifi
differ
effici
like
signific
unknown
number
provirus
insert
far
away
alu
site
effici
amplifi
corollari
assert
frequenc
integr
within
rest
cell
previous
determin
use
clonal
pcr
standard
like
underestim
superior
integr
standard
would
contain
multipl
uniqu
integr
site
thousand
integr
randomli
rang
distanc
nearest
alu
repeat
sequenc
recent
first
fulli
quantit
onestep
kinet
alu
pcr
assay
integr
describ
shown
capabl
detect
one
proviru
target
cell
import
appropri
standard
emphas
particular
need
standard
accur
reflect
random
natur
integr
integr
standard
gener
infect
cell
high
titer
viru
follow
cultur
period
least
day
allow
unintegr
form
dna
elimin
genom
dna
prepar
order
studi
effici
integr
rest
cell
requir
fulli
quantit
method
improv
sensit
hand
onestep
pcr
method
lack
requisit
sensit
use
primari
cell
accordingli
nest
pcr
strategi
implement
use
condit
deoxynucleosid
triphosph
dntp
primer
enzym
limit
nonkinet
preamplif
alugag
sequenc
preamplif
follow
realtim
pcr
assay
quantit
long
termin
repeat
ltr
sequenc
use
molecular
beacon
detect
parallel
develop
altern
integr
standard
cell
line
wherein
larg
number
target
cell
infect
hightit
randomli
integr
replicationincompet
construct
contain
antibiot
resist
cassett
prolong
antibiot
select
perform
prior
prepar
genom
dna
cell
latter
step
ensur
everi
cell
popul
contain
least
one
proviru
dna
within
cell
integr
larg
number
target
initi
infect
insur
integr
event
numer
occur
larg
rang
distanc
genom
alu
element
cell
line
plasmid
virus
tlymphoblastoid
cell
line
cemss
maintain
densiti
per
ml
per
ml
respect
cultur
medium
rpmi
supplement
heatinactiv
fetal
bovin
serum
mm
hepe
ph
penicillinstreptomycin
invitrogen
life
technolog
order
prepar
cell
line
revdefici
resistanceconf
provir
vector
deriv
repair
nef
gene
sequenc
insert
ribosom
entri
site
downstream
neomycin
resist
cassett
cell
cotransfect
three
plasmid
name
ii
pcrev
iii
pvsv
g
phitg
twentyfour
hour
transfect
supernat
contain
pseudotyp
viru
centrifug
g
min
treat
g
rnasefre
dnase
roch
ml
min
room
temperatur
presenc
mm
mgcl
steril
filter
syring
filter
acrodisc
ht
tuffryn
pall
gelman
cemss
cell
express
refer
prepar
describ
previous
enrich
fluoresc
activ
cell
sort
popul
express
moder
level
approxim
molecul
data
shown
infect
perform
spinocul
describ
prepar
cell
line
cemss
cell
infect
pseudotyp
viru
describ
spinocul
briefli
cemss
cell
mix
ml
viral
stock
ng
gag
ml
place
six
well
flatbottom
sixwel
tissu
cultur
plate
ml
suspens
per
well
plate
seal
plastic
bag
centrifug
micropl
carrier
g
h
cell
collect
wash
ml
icecold
cultur
medium
rpmi
heatinactiv
fetal
calf
serum
mm
hepe
ph
penicillinstreptomycin
infect
cell
cultur
day
addit
g
geneticin
invitrogen
life
technolog
ml
upon
initi
addit
approxim
cell
die
cell
select
addit
week
select
cell
lyse
densiti
ml
follow
buffer
mm
trishcl
ph
mm
edta
mm
cacl
sodium
dodecyl
sulfat
triton
mg
proteinas
k
sigma
ml
lysat
digest
overnight
proteas
heat
inactiv
min
aliquot
ml
store
prior
assay
serial
dilut
genom
dna
made
mm
trishcl
ph
mm
edta
sodium
dodecyl
sulfat
triton
supplement
g
poli
ra
ml
reduc
nonspecif
adsorpt
dna
wall
reaction
vessel
southern
blot
select
total
dna
prepar
describ
elsewher
dneasi
tissu
system
qiagen
uninfect
cemss
cell
cemss
cell
acut
infect
iiib
ng
gag
ml
spinocul
h
prior
harvest
electrophoresi
agaros
gel
load
g
dna
per
lane
dna
transfer
charg
nylon
membran
genescreen
plu
perkinelm
membran
prehybrid
perfecthyb
plu
hybrid
buffer
sigma
probe
p
dctplabel
probe
gener
random
prime
radprim
kit
invitrogen
entir
iiib
genom
wash
blot
expos
biomax
mr
film
kodak
biomax
transcreen
le
intensifi
screen
kodak
week
twostep
pcr
amplif
initi
nonkinet
preamplif
perform
dilut
cell
well
dilut
unknown
essenti
preamplifi
seri
dilut
standard
unknown
insur
pcr
substrat
limit
reaction
reagent
limit
lack
dose
respons
compar
dilut
standard
curv
sequenc
preamplif
primer
follow
genom
alu
forward
tcc
caa
agt
gct
ggg
att
aca
gag
revers
ctc
gca
ccc
atc
tct
ctc
reaction
condit
mm
trishcl
ph
mm
mgcl
mm
concentr
mix
dntp
mm
kcl
nm
alu
forward
primer
nm
gag
revers
primer
u
platinum
taq
dna
polymeras
invitrogen
life
technolog
thermal
cycler
dna
engin
mj
research
program
perform
hot
start
follow
step
follow
denatur
min
anneal
min
extens
min
linear
oneway
amplif
also
monitor
perform
preamplif
pcr
either
gag
primer
alon
alu
primer
alon
secondround
realtim
quantit
pcr
perform
use
l
materi
preamplif
match
dilut
nonpreamplifi
nonpreamplifi
unknown
acut
infect
cell
presenc
absenc
integras
inhibitor
run
copi
number
standard
prepar
grade
dose
cell
sequenc
primer
follow
ltr
forward
tca
ata
aag
ctt
gcc
ttg
ltr
revers
aca
ctg
act
aaa
agg
gtc
ltr
molecular
beacon
probe
label
terminu
report
fluorophor
fam
terminu
quencher
benzen
dabcyl
follow
sequenc
agt
gcc
cgt
ctg
ttg
tgt
gac
tct
express
integr
ratio
provirus
per
target
cell
kinet
pcr
assay
dna
use
determin
cell
number
plate
use
quantit
standard
curv
cellular
dna
prepar
serial
dilut
cemss
lysat
start
ml
prepar
describ
sequenc
forward
revers
primer
respect
molecular
beacon
sequenc
react
ion
carri
volum
l
contain
mm
trishcl
ph
mm
kcl
mm
mgcl
nm
rox
mm
concentr
mix
dntp
concentr
forward
revers
primer
nm
molecular
beacon
probe
u
platinum
taq
dna
polymeras
thermal
program
describ
contain
integr
dna
gener
cell
line
spinocul
util
deposit
larg
fig
describ
previous
total
dna
prepar
follow
prolong
antibiot
select
addit
dna
prepar
cemss
cell
expos
replicationcompet
iiib
spinocul
cultur
h
uninfect
cemss
cell
equal
amount
dna
prepar
glane
appli
lane
agaros
gel
fig
southern
blot
reveal
integr
linear
circular
form
dna
acut
infect
cell
fig
left
lane
howev
integr
dna
could
detect
fig
center
lane
signal
blot
specif
sinc
absent
uninfect
cemss
cell
number
copi
dna
dilut
nonpreamplifi
shown
correspond
amplif
curv
number
determin
use
copi
number
standard
fig
sinc
dna
integr
fig
number
reflect
total
number
provirus
reaction
b
number
provirus
per
reaction
nonpreamplifi
assign
kinet
pcr
signal
preamplifi
second
standard
line
construct
amplif
perform
duplic
consist
close
reproduc
c
logarithm
regress
preamplifi
signal
eight
provirus
per
sampl
could
reliabl
measur
run
fig
right
lane
ensur
cdna
integr
lysat
prepar
prolong
exposur
therebi
expand
subpopul
cell
express
neomycin
resist
phenotyp
effici
although
select
reduc
random
integr
site
repres
select
popul
degre
select
pressur
favor
alugag
distanc
specif
length
standard
assay
initi
nonkinet
alugag
preamplif
substrat
enzym
excess
produc
heterogen
amplicon
vari
length
fig
aliquot
amplicon
match
aliquot
nonpreamplifi
standard
unknown
subject
quantit
kinet
pcr
detect
dna
within
ltr
produc
homogen
amplicon
bp
length
fig
standard
assay
one
must
first
determin
copi
number
nonpreamplifi
isthat
dna
subject
initi
nonkinet
alugag
pcr
use
grade
dose
accur
count
cell
two
provirus
per
genom
two
separ
sampl
cell
suspens
count
trypan
blue
dye
four
hemacytomet
count
perform
sampl
eight
cell
count
averag
kinet
pcr
amplif
ltr
sequenc
fig
perform
standard
dilut
nonpreamplifi
dna
integr
fig
known
hiv
copi
number
standard
use
measur
appar
integr
dna
content
fig
contain
mean
provirus
per
cell
next
second
standard
curv
construct
appar
integr
copi
number
nonpreamplifi
dilut
assign
kinet
pcr
signal
preamplifi
dilut
fig
second
standard
curv
use
determin
number
provirus
per
reaction
preamplifi
dilut
unknown
extent
present
nonintegr
hiv
sequenc
unknown
part
bulk
hiv
copi
number
amplifi
linearli
gag
prime
preamplif
correct
signal
contribut
unintegr
dna
routin
subtract
total
signal
includ
gagonli
linear
preamplif
control
elabor
fig
mani
case
reveal
express
integr
rate
ratio
mean
number
provirus
per
target
cell
determin
ratio
assay
expand
directli
detect
cell
number
kinet
pcr
perform
dna
standard
use
assay
must
match
unknown
term
ploidi
exampl
euploid
primari
cell
studi
appropri
standard
would
grade
dose
genom
dna
euploid
peripher
blood
mononuclear
cell
infect
aneuploid
tumor
cell
line
compar
standard
prepar
match
uninfect
cell
linear
dynam
rang
assay
typic
kinet
pcr
amplif
bulk
copi
number
use
standard
fig
sigmoid
amplif
curv
observ
million
copi
per
reaction
dynam
rang
span
log
decim
logarithm
copi
number
plot
threshold
cycl
number
limit
strongli
linear
relationship
observ
fig
regress
line
usual
intercept
near
cycl
maximum
cycl
number
per
reaction
neg
slope
close
threshold
cycl
per
increas
analyt
concentr
satur
observ
copi
number
higher
million
copi
per
well
cellsml
amplif
curv
observ
limit
copi
per
well
exampl
fig
notempl
control
data
shown
run
standard
curv
use
primer
bind
r
region
ltr
use
determin
experiment
proviru
content
dilut
seri
nonpreamplifi
fig
number
assign
alugag
signal
aris
match
dilut
seri
preamplifi
fig
first
pcr
serv
preamplif
alugag
signal
reduc
threshold
cycl
number
preamplifi
kinet
pcr
shift
curv
left
fig
cycl
correspond
roughli
log
amplif
observ
amplif
factor
averag
perform
within
one
assay
list
tabl
particular
assay
provirus
sampl
detect
sinc
sampl
contain
cell
proviru
cell
could
reliabl
measur
run
sensit
suffici
measur
integr
primari
lymphocyt
rel
uncertainti
increas
increas
dilut
like
due
accumul
sampl
error
within
run
assay
reproduc
duplic
reaction
plate
contain
master
mix
typic
overlay
close
fig
compar
standard
fig
dynam
rang
preamplifi
rel
narrow
usual
log
limit
attribut
sigmoid
amplif
characterist
nonkinet
preamplif
step
within
rang
howev
standard
curv
linear
fig
intercept
regress
line
typic
correspond
threshold
cycl
midtwenti
slope
roughli
cycl
per
increas
analyt
concentr
sensit
specif
assay
determin
whether
linear
oneway
amplif
unintegr
fig
construct
lack
alu
repeat
either
gag
primer
alon
alugag
primer
pair
use
preamplif
similar
signal
obtain
correspond
roughli
fivefold
amplif
expect
alu
primer
use
alon
preamplif
piiib
signal
obtain
compar
nonpreamplifi
plasmid
sampl
signal
correspond
copi
unintegr
dna
toler
assay
sinc
appear
higher
threshold
cycl
number
dilut
isderiv
preamplifi
standard
curv
sensit
assay
examin
perform
oneway
bidirect
preamplif
heterogen
templat
contain
exclus
integr
dna
fig
oneway
amplif
contribut
lowlevel
interf
signal
correspond
fivefold
amplif
nonpreamplifi
standard
contrast
bidirect
alugag
preamplif
result
log
net
amplif
approxim
reduct
threshold
cycl
number
taken
togeth
find
indic
interf
signal
oneway
amplif
small
subtract
total
signal
obtain
given
sampl
account
signal
becom
import
earli
time
point
follow
acut
vitro
infect
provirus
compris
minor
total
dna
present
next
assay
acut
infect
cell
cultur
h
spinocul
fig
found
oneway
amplif
gag
primer
result
small
increas
signal
preamplif
acut
infect
sampl
log
increas
signal
preamplif
observ
bidirect
alugag
amplif
rel
modest
shift
due
predomin
unintegr
dna
earli
time
point
specif
sampl
mean
copi
viral
ltr
dna
per
cell
provirus
per
cell
n
assay
specif
integr
cell
acut
infect
presenc
diketo
acid
integras
inhibitor
merck
integr
detect
fig
fivefold
bidirect
alugag
amplif
seen
inhibit
signal
similar
gagonli
preamplif
signal
obtain
infect
perform
use
deriv
integras
mutant
also
dramat
reduc
level
similar
gagonli
preamplif
fig
describ
assay
integr
base
realtim
quantit
alugag
pcr
assay
suffici
sensit
specif
permit
use
studi
nonproduct
latent
infect
rest
primari
cell
reservoir
cell
accumul
earli
cours
infect
vivo
viru
within
cell
evad
antivir
immun
respons
antiretrovir
therapi
prevent
cure
hiv
diseas
current
medic
postintegr
viral
latenc
first
document
untreat
individu
provirus
estim
present
rest
cell
blood
lymph
node
howev
due
inher
limit
method
use
importantli
lack
polyclon
standard
see
frequenc
may
well
underestim
infecti
viru
could
recov
cell
treat
mitogen
phytohemagglutinin
presenc
antigenpres
cell
omin
frequenc
proviruscontain
rest
cell
appear
chang
substanti
earli
advanc
hiv
diseas
influenc
effect
therapi
reduc
plasma
viremia
undetect
level
find
yet
confirm
use
fulli
quantit
integr
assay
rest
cell
contain
provirus
memori
phenotyp
howev
fact
phenotyp
cast
doubt
upon
dogma
full
mitot
tcell
activ
requir
integr
occur
mechan
postintegr
latenc
establish
maintain
known
cell
may
novel
multipl
step
life
cycl
ineffici
inhibit
rest
cell
well
establish
major
ineffici
exist
revers
transcript
cell
pauciti
substrat
revers
transcriptas
part
respons
block
sinc
ineffici
partial
overcom
supplement
rest
cell
exogen
deoxyribonucleosid
yet
addit
ineffici
must
exist
downstream
revers
transcript
fig
sensit
specif
assay
plasmid
piiib
contain
fulllength
molecular
clone
iiib
human
dna
particular
alu
sequenc
oneway
preamplif
alu
primer
alon
orang
produc
kinet
pcr
signal
compar
signal
match
dose
nonpreamplifi
plasmid
green
signal
roughli
fivefold
higher
aris
either
oneway
preamplif
gag
primer
alon
black
bidirect
preamplif
alu
gag
primer
b
oneway
preamplif
use
either
alu
primer
alon
orang
gag
primer
alon
black
produc
roughli
fivefold
amplif
rel
match
sampl
nonpreamplifi
green
contrast
kinet
pcr
signal
obtain
follow
bidirect
alugag
preamplif
blue
shift
roughli
threshold
cycl
left
correspond
amplif
nonpreamplifi
control
c
twelv
hour
spinocul
cell
ng
gag
ml
provirus
compris
minor
dna
integr
signal
acut
infect
cell
red
fall
within
linear
rang
preamplifi
blue
curv
correspond
provirus
per
reaction
oneway
preamplif
gag
primer
alon
black
gener
signal
similar
signal
obtain
infect
perform
presenc
dose
integras
inhibitor
gray
signal
subtract
alugag
signal
produc
via
linear
amplif
integr
unintegr
dna
integr
detect
h
spinocul
cell
deriv
integrasedefect
mutant
viru
instead
alugag
preamplif
result
fivefold
amplif
similar
oneway
gag
amplif
april
guest
http
jviasmorg
sinc
progeni
virion
releas
latent
infect
cell
absenc
immun
activ
even
nucleosid
pool
exogen
enhanc
quantit
integr
assay
develop
prove
use
mechanist
studi
dissect
addit
ineffici
also
prove
applic
clinic
epidemiolog
studi
viral
integr
assess
effect
futur
antiretrovir
treatment
erad
latent
reservoir
